Jill DeSimone - Jan 4, 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 05:02 PM
Previous filing
May 24, 2022
Next filing
Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCT Stock Option Award $0 +50K $0.00 50K Jan 4, 2023 Common Stock 50K $1.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on February 4, 2023, subject to the recipient's continued service.